Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Cambium Bio Limited (ASX: CMB) - Share Price and Research
- Current share price for CMB : $0.009
--
CMB General Information +
| ASX Code | CMB |
| Website | http://www.regeneus.com.au |
| Industry/Sector | Biotechnology |
| Market Cap ($M) | 6 |
| CMB Share Price | $0.009 |
| Day High | $0.010 |
| Day Low | $0.009 |
| Last Close | $0.009 |
| CMB Share Price Movement | - ( No change ) |
Prices as at 12:20, 26 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
CMB Related Research
Cambium Bio Limited (CMB) Upcoming Dividends & Yields
There are no dividends for Cambium Bio Limited (CMB). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Cambium Bio Limited (CMB) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Change in substantial holding | 11 Apr 2024 2:04PM | $0.010 | $0.009 | $0.009 | fallen by 10% |
| Initial Director's Interest Notice - Tseng | 11 Apr 2024 9:32AM | n/a | $0.009 | $0.009 | n/a |
| Director Appointment Dr. Tseng | 11 Apr 2024 9:31AM | n/a | $0.009 | $0.009 | n/a |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Cambium Bio Limited (CMB) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
CMB Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cambium Bio (CMB) | $6M | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| CSL (CSL) | $134,813M | -0.0712 | 0.1072 | 0.1864 | 40.8293 | 36.8764 | 31.0830 | 1.28% | 1.20% | 1.35% |
| Clinuvel Pharmaceuticals (CUV) | $746M | 0.4665 | 0.2049 | 0.1566 | 25.1946 | 20.9100 | 18.0792 | 0.34% | 0.47% | 0.54% |
| Mesoblast (MSB) | $1,028M | -0.1037 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Telix Pharmaceuticals (TLX) | $4,725M | -1.3767 | 0.0000 | 0.0000 | 113.3122 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
CMB Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.00 | 0.00 |
| Market | 0.54 | 15.00 | 1.10 | 1.05 |
| Sector | 1.36 | 21.30 | 1.92 | 0.96 |
CMB Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Yu-Hung Sebastian Tseng | Non-Executive Director | 11 Apr 2024 |
Cambium Bio Limited (CMB) Changes in Directors' Interest & Trades
There are no directors' trades from Cambium Bio Limited (CMB). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
FAQs about Cambium Bio Limited (CMB)
What is the current share price of Cambium Bio Limited (CMB)?
Cambium Bio Limited's (CMB) current share price is $0.01. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -30.77% below CMB's 12-month high of $0.01 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Cambium Bio Limited (CMB)?
Relative to the previous close share price of $0.01, Cambium Bio Limited's (CMB) current share price of $0.01 constitutes a movement of or 0%. Cambium Bio Limited's (CMB) share price movement is 0% when compared to 7 days ago and is -30.77% below CMB's 52-week high of $0.01.
What is the 52-week high share price for Cambium Bio Limited (CMB)?
Cambium Bio Limited's (CMB) 52-week high is $0.01 which was reached on 11 Apr 2024. Relative to this, CMB's current share price of $0.01 constitutes a $0.00 or -30.77% drop since that high of $0.01 per CMB share.
What is the 52-week low share price for Cambium Bio Limited (CMB)?
Cambium Bio Limited's (CMB) 52-week low is $0.01 which was reached on 15 Apr 2024. Relative to this, CMB's current share price of $0.01 constitutes a $0.00 or 12.50% gain since that low of $0.01 per CMB share.
What is the daily average trading volume for Cambium Bio Limited (CMB)?
Over the last 12 months, Cambium Bio Limited (CMB) has a daily average trading volume of 657,067 CMB shares per day.
What is the dividend yield for Cambium Bio Limited (CMB)?
Cambium Bio Limited (CMB) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for CMB is a ratio that tells you the percentage of Cambium Bio Limited's (CMB) share price that it pays out in dividends each year.
When does Cambium Bio Limited (CMB) release its next Annual Report?
Cambium Bio Limited (CMB) will release its next Annual Report on n/a. Cambium Bio Limited's (CMB) last annual report was released on n/a.
In which sector is Cambium Bio Limited (CMB) classified?
Cambium Bio Limited (CMB) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for Cambium Bio Limited (CMB)?
The price-to-earnings (P/E) ratio for Cambium Bio Limited (CMB) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Cambium Bio Limited's (CMB) share price to its earnings per CMB share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
